Annual Drug Patent Expirations for FUSILEV Fusilev is a drug marketed by Acrotech and is included in one NDA. There is one patent protecting this drug and two Paragraph IV…
The post New patent expiration for Acrotech drug FUSILEV appeared first on Drug…
BYDUREON PEN (exenatide synthetic) Astrazeneca ab Patent: 7,223,440 Expiration: Mar 3, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirations …
Drug Patent Expirations for the Week of February 27, 2022 Read Post »
Annual Drug Patent Expirations for TEKTURNA+HCT Tekturna Hct is a drug marketed by Noden Pharma and is included in one NDA. It is available from one supplier. There are two…
The post New patent expiration for Noden Pharma drug TEKTURNA HCT appeared fir…
New patent expiration for Noden Pharma drug TEKTURNA HCT Read Post »
Annual Drug Patent Expirations for BYDUREON+BCISE Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are fifteen…
The post New patent expiration for Astrazeneca Ab drug BYDUREON BCIS…
New patent expiration for Astrazeneca Ab drug BYDUREON BCISE Read Post »
Annual Drug Patent Expirations for SAFYRAL Safyral is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from two suppliers. There are three patents…
The post New patent expiration for Bayer Hlthcare drug SAFYRAL appeared fir…
New patent expiration for Bayer Hlthcare drug SAFYRAL Read Post »
Annual Drug Patent Expirations for BEYAZ Beyaz is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from two suppliers. There are four patents…
The post New patent expiration for Bayer Hlthcare drug BEYAZ appeared first on D…
New patent expiration for Bayer Hlthcare drug BEYAZ Read Post »
Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-two…
The post New patent expiration for Astrazeneca Ab drug BYDUREON PEN a…
New patent expiration for Astrazeneca Ab drug BYDUREON PEN Read Post »
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are twenty-three patents…
The post New patent expiration for Astrazeneca Ab drug BYDUREON ap…
New patent expiration for Astrazeneca Ab drug BYDUREON Read Post »
Annual Drug Patent Expirations for PRISTIQ Pristiq is a drug marketed by Pf Prism Cv and is included in one NDA. It is available from four suppliers. There are two…
The post New patent expiration for Pf Prism drug PRISTIQ appeared first on DrugPatentWa…
Annual Drug Patent Expirations for PEPCID+AC Pepcid Ac is a drug marketed by J And J Consumer Inc and is included in three NDAs. It is available from two suppliers.…
The post New patent expiration for J And drug PEPCID AC appeared first on DrugPatentWa…